Jazz Pharmaceuticals plc
NASDAQ: JAZZ
$107.10
-$1.80 (-1.7%)
Closing price April 17, 2024
One area to look at in this overbought and pricey market is pharmaceuticals. These five now are considered to be “deep value” plays at Merrill Lynch.
Published:
ImmunoGen announced this week that it has decided to partner with Jazz Pharmaceuticals, and investors have pushed Immunogen shares to a new 52-week high.
Published:
Last Updated:
ImmunoGen has decided to partner with Jazz Pharmaceuticals for the development and commercialization of two early-stage, hematology-related antibody-drug conjugate programs.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Monday include Applied Materials, Cerner, Cisco Systems, Johnson & Johnson, Level 3 Communications and Salesforce.com.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Thursday include AMD, Panera, SeaWorld, T-Mobile, Walgreens and 8Point3.
Published:
Last Updated:
Trump said last week that companies in the health care sector are “getting away with murder,” and that something had to change. The sector has pulled back slightly since then, but there are still...
Published:
Last Updated:
All three of these specialty pharmaceutical stocks come with a fair share of risk but provide big upside potential as well.
Published:
Last Updated:
Jazz Pharmaceuticals announced Tuesday morning that it has reached a definitive agreement to acquire Celator Pharmaceuticals for about $1.5 billion.
Published:
Last Updated:
This is going to be a big year in biotech, with a host of drugs set to undergo FDA scrutiny. These four companies with promising candidates all have dates with the agency this year.
Published:
Last Updated:
Stocks were indicated surprisingly higher after international markets recovered more than might have been expected. The trend that has been static for 4 years now is that investors want to buy stocks...
Published:
Last Updated:
Friday's top analyst upgrades and downgrades include Cisco Systems, EMC, GameStop, Novavax, Tesla Motors and Yahoo.
Published:
Friday's top analyst upgrades, downgrades and initiations from 24/7 Wall St. include Wal-Mart, Garmin, DSW, Kinder Morgan and Hasbro.
Published:
A recent research piece from the biotech analysts at Stifel focused on three top stocks to buy with outstanding potential.
Published:
The analysts at Piper Jaffray are very positive on four top specialty pharmaceutical stocks with potential for a strong fourth-quarter rally in their shares.
Published:
Cowen asked the analysts which stocks should be on their shopping lists. Here are the six with the biggest upside potential.
Published: